JPS6263863A - Blood-substituting fluid for research of artificial organ or the like - Google Patents

Blood-substituting fluid for research of artificial organ or the like

Info

Publication number
JPS6263863A
JPS6263863A JP20364585A JP20364585A JPS6263863A JP S6263863 A JPS6263863 A JP S6263863A JP 20364585 A JP20364585 A JP 20364585A JP 20364585 A JP20364585 A JP 20364585A JP S6263863 A JPS6263863 A JP S6263863A
Authority
JP
Japan
Prior art keywords
blood
fluid
microcapsules
research
artificial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP20364585A
Other languages
Japanese (ja)
Inventor
Yoshinori Murakami
村上 芳則
Kensaku Imaichi
今市 憲作
Shigeru Goto
滋 後藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP20364585A priority Critical patent/JPS6263863A/en
Publication of JPS6263863A publication Critical patent/JPS6263863A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To obtain an inexpensive blood-substituting fluid by mixing microcapsules contg. fluid such as physiological salt soln. or glycerol as a core material with Neuton fluid such as physiological salt soln. or glycerol soln. CONSTITUTION:The microcapsules in which the physiological salt soln. is included, have approximately the same size as the size of the red blood cells in blood and have 7-8 micron average particle size are mixed with the physiological salt soln. which is the Neuton fluid at 45% similar to the volumetric ratio of the blood cells. The microcapsules are formed by using a synthetic resin material such as, for example, vinyl chloride, as a film and including the physiological salt soln. thereon. The microcapsules are formed to disk-shaped flat bodies by heating, etc.

Description

【発明の詳細な説明】 産業上の利用分野 本発明は、人工臓器や生体内の血流の研究用等の血液代
替流体に関する。
DETAILED DESCRIPTION OF THE INVENTION Field of the Invention The present invention relates to a blood substitute fluid for research on artificial organs and blood flow in living bodies.

従来の技術 近年、人工心臓、人工血管、血液ポンプ等の人工臓器の
開発が盛んで、着実に実用化されつつある。
BACKGROUND OF THE INVENTION In recent years, artificial organs such as artificial hearts, artificial blood vessels, and blood pumps have been actively developed and are steadily being put into practical use.

そして、これらの人工臓器の開発や研究にあたっては、
生理食塩水や牛等の動物の血液を使用して作動テストや
機能テストを行っているものである。
In developing and researching these artificial organs,
Operation and function tests are conducted using physiological saline and the blood of animals such as cows.

発明が解決しようとする問題点 しかし、生理食塩水は、ニュートン流体で、非ニユート
ン流体の血液とは流体特性が全く異なるものであるとと
もに血球破壊のシミュレーションなどは全く不可能であ
る。また動物等の血液は人間の血液と類似しているもの
の、腐敗や変質などの問題もあり、薬剤を混入するとと
もに低温保存や冷凍保存等で特別に保存しなければなら
ず、取り扱える場所が限定されるものである。また、動
物(固体の差異や採血時からの経時等によって流体特性
や血球強度などが大いに異なり、再現性のある標準デー
タを採取することが困難であった。
Problems to be Solved by the Invention However, physiological saline is a Newtonian fluid and has completely different fluid characteristics from blood, which is a non-Newtonian fluid, and it is completely impossible to simulate blood cell destruction. In addition, although animal blood is similar to human blood, it has problems such as putrefaction and deterioration, so it must be laced with drugs and must be specially preserved at low temperatures or frozen, which limits the number of places where it can be handled. It is something that will be done. In addition, fluid characteristics and blood cell strength vary greatly depending on the animal (individual individual, time elapsed since blood collection, etc.), making it difficult to collect reproducible standard data.

問題点を解決するための手段 本発明は上記のような点に鑑みたもので、生理食塩水、
グリセリン溶液等の安価で取扱い容易で、入手簡単なニ
ュートン流体に生理食塩水、グリセリン溶液等の安価で
取扱い容易で、入手簡単な流体を内包した直径が数ミク
ロンないし十数ミクロン位のマイクロカプセルを混合す
るとともに、人工m器の開発や動作特性、血流等の研究
用に血液と同一または類似の流体特性とするために上記
二ニートン流体とマイクロカプセルとの体積比率を血液
中の血漿水と血球との体積比率とほぼ同様に混合形成し
て、所要の流体等を簡単に入手できて容易に生成でき、
しかも吹扱いも容易で血液と同様の非ニュー トン流体
で血液の代替となる標準の流体特性のものが得られ、血
球破壊のシミュレーション等も行えて人工臓器の開発や
研究を大いに促進できる人工臓器研究用等の血液代替流
体を提供するにある。
Means for Solving the Problems The present invention was made in view of the above points, and uses physiological saline,
Microcapsules with a diameter of several microns to a dozen microns are encapsulated with cheap, easy-to-handle, and easily-obtained Newtonian fluids such as glycerin solutions, physiological saline, and glycerin solutions. At the same time, the volume ratio of the above-mentioned two-ton fluid and microcapsules is adjusted to the plasma water in blood in order to obtain fluid characteristics that are the same or similar to blood for the development of artificial devices, research on operating characteristics, blood flow, etc. It can be mixed and formed with almost the same volume ratio as blood cells, and the required fluid etc. can be easily obtained and easily produced.
In addition, it is easy to handle, is a non-Newtonian fluid similar to blood, has standard fluid characteristics as a substitute for blood, and can simulate blood cell destruction, greatly promoting the development and research of artificial organs. The purpose is to provide blood substitute fluids for research purposes.

実施例 以下、本発明を実施例にもとすいて説明する。Example Hereinafter, the present invention will be explained based on examples.

第一実施例 本発明の血液代替流体の一実施例としては、生理食塩水
のニュートン流体に同じく生理食塩水を内包したマイク
ロカプセルを混合して生成するものである。生理食塩水
は、通常の医療用のための等張溶液としたニュートン流
体で、このニュートン流体の生理食塩水に生理食塩水を
内包した血液中の赤血球とほぼ同じ大きさの平均粒子径
が7〜8ミクロンのマイクロカプセルを体積比率が血液
中の血漿水と血球の体積比と同様のほぼ45%として混
合するものである。マイクロカプセルは、たとえば塩化
ビニルのような合成樹脂材を被膜とし、生理食塩水を内
包したものである。そして、このマイクロカプセルを加
熱等により円盤状の偏平体とし、所定の網目のフィルタ
ーで上記混合液をこして、直径が7〜8ミクロンの上記
した赤血球と同様の粒状体に生成しているものである。
First Embodiment An embodiment of the blood substitute fluid of the present invention is produced by mixing Newtonian fluid of physiological saline with microcapsules encapsulating physiological saline. Physiological saline is a Newtonian fluid made into an isotonic solution for normal medical use, and the average particle diameter of this Newtonian fluid saline is approximately the same size as red blood cells in blood containing physiological saline. Microcapsules of ~8 microns are mixed at a volume ratio of approximately 45%, which is similar to the volume ratio of plasma water and blood cells in blood. Microcapsules are coated with a synthetic resin material such as vinyl chloride and encapsulate physiological saline. Then, the microcapsules are made into disk-shaped flat bodies by heating, etc., and the mixture is filtered through a filter with a predetermined mesh size, resulting in granular bodies with a diameter of 7 to 8 microns similar to the above-mentioned red blood cells. It is.

このようにして生成した粒状体を生理食塩水に上記した
45%の体積比率で混合すれば、所望の血液代替流体が
生成できるものである。
If the granules thus produced are mixed with physiological saline at a volume ratio of 45%, a desired blood substitute fluid can be produced.

作用 しかして、上記のように生成した血液代替流体を所定の
温度にして人工心臓装置や人工心肺装置等に使用すれば
、血液代替流体を血液中の主要部分である血漿水と赤血
球との状態のように構成しているため、非ニユートン流
体の血液にきわめて類似した流体特性が得られ、人工心
臓装置や人工心肺装置のシミュレーションテストを正確
に行えて、人工心臓や血液ポンプの作動状況や機能特性
のばらつきのない、正確に再現性のある標準データが採
取できるものである。さらに、上記シミュレーションテ
ストの後に顕微鏡等を使用してマイクロカプセルの破壊
量を測定すことにより、人工心臓や血液ポンプによる血
球破壊を定量化して測定することができるものである。
Function: If the blood substitute fluid produced as described above is heated to a predetermined temperature and used in an artificial heart device or an artificial heart-lung device, the blood substitute fluid will be able to maintain the state of plasma water and red blood cells, which are the main parts of blood. Because of this configuration, it is possible to obtain fluid characteristics extremely similar to blood, which is a non-Newtonian fluid, making it possible to accurately perform simulation tests on artificial heart devices and artificial heart-lung devices, and to evaluate the operating status and functions of artificial hearts and blood pumps. Accurately reproducible standard data with no variation in characteristics can be collected. Furthermore, by measuring the amount of microcapsule destruction using a microscope or the like after the above simulation test, it is possible to quantify and measure the destruction of blood cells caused by an artificial heart or blood pump.

また、人工心臓や血液ポンプ中の流れの分布状況や人工
血管中の流れの分布状況、よどみの状況等を可視化でき
たり、再現性のある詳細なデータを採取することも容易
に行えるようになり、人工臓器の流体力学面から機能性
の改善を適確に行うことができるものである。
In addition, it has become possible to visualize flow distribution in artificial hearts and blood pumps, flow distribution in artificial blood vessels, stagnation, etc., and to easily collect reproducible and detailed data. , it is possible to accurately improve the functionality of artificial organs from the viewpoint of fluid dynamics.

また、上記実施例に記述しているように、構成流体や材
料は安価で、入手しやすいものばかりであり、製造も困
難でなく、しかもきわめて取扱いやすいため、人工臓器
のシミュレーションテストが広範囲にわたって、法分野
の人々にも行えて、人工臓器の多方面にわたる研究が可
能となるとともに、そのテストデータは牛などの動物血
液を用いたものと異なって、比較検討し易いものである
In addition, as described in the above examples, the constituent fluids and materials are inexpensive and easily available, are not difficult to manufacture, and are extremely easy to handle, so simulation tests of artificial organs have been carried out extensively. It can be performed by people in the legal field, making it possible to conduct a wide range of research on artificial organs, and the test data is easy to compare and study, unlike those using animal blood such as cows.

第二実施例 本実施例では、一定量のしょ糖を均一に溶解した生理食
塩水を内包したマイクロカプセルを生成し、前記と同様
に生理食塩水と所定の体積比率にて混合して血液代替流
体を構成するものである。
Second Example In this example, microcapsules encapsulating physiological saline in which a certain amount of sucrose is uniformly dissolved are produced and mixed with physiological saline at a predetermined volume ratio in the same manner as above to obtain a blood substitute fluid. It constitutes.

本実施例では、人工心臓や血液ポンプでマイクロカプセ
ルが破壊した破損量を、血液代替流体中に流出したしょ
糖の濃度を測定することにより算出することができるも
のである。特に、マイクロカプセルの破壊率を濃度計に
よって定置的に測定できて、好ましいものである。
In this example, the amount of microcapsule damage caused by an artificial heart or blood pump can be calculated by measuring the concentration of sucrose that has flowed into the blood substitute fluid. In particular, it is preferable because the destruction rate of microcapsules can be measured stationarily using a densitometer.

なお、しょ糖のかわりにぶどう糖、その他の糖分を溶解
することもでき、また色素を有する染料物質を上記と同
様にマイクロカプセルに内包させて色度等によって破壊
状態を測定することもできるものである。
Note that glucose or other sugars can be dissolved instead of sucrose, and the state of destruction can also be measured by chromaticity, etc. by encapsulating a dye substance with a pigment in microcapsules in the same way as above. .

第三実施例 本実施例では、シリコンオイル等の油性物質を内包して
マイクロカプセルとするものである。
Third Embodiment In this embodiment, an oily substance such as silicone oil is encapsulated to form a microcapsule.

本実施例では、破壊したマイクロカプセルから流出した
油性分の人工臓器などの流路壁面への付着を観察するこ
とが容易となり、血栓の成長についての測定が可能なも
のである。
In this example, it is easy to observe the adhesion of the oily substance flowing out from the destroyed microcapsules to the wall surface of the channel of an artificial organ, etc., and it is possible to measure the growth of a thrombus.

他の実施例 以上の実施例では、マイクロカプセルを混合する流体を
生理食塩水としたが安価に入手できるグリセリン溶液等
の他のニュー トン流体を利用することも可能であり、
またマイクロカプセルとの混合比率も血液の血漿水と血
球との比率のほぼ45%が好ましいが、異常状態の研究
用等のために数パーセントから90パーセントにわたっ
て必要に応じ変化させてもよいものである。
Other Examples In the above examples, physiological saline was used as the fluid for mixing the microcapsules, but it is also possible to use other Newtonian fluids such as glycerin solutions that are available at low cost.
In addition, the mixing ratio with microcapsules is preferably approximately 45% of the ratio of blood plasma water to blood cells, but it may be varied as necessary from a few percent to 90% for purposes such as research on abnormal conditions. be.

また、マイクロカプセルの形状として、血球の大部分を
占める赤血球の形状と同一状の円盤状に形成したが、単
純な球状体のままとすることもできるものである。
Furthermore, although the microcapsules were formed into a disc shape that is the same as the shape of red blood cells that make up the majority of blood cells, they can also be formed into simple spherical shapes.

さらに、マイクロカプセルの被膜物質としては、塩化ビ
ニリデン、ポリエチレン、ポリプロピレン、ナイロン、
シリコーン等の合成樹脂材やゼラチン等の高分子材料を
上記と同様にして行うこともできるものであり、マイク
ロカプセル化の手段としては、公知の化学的、物理的、
機械的なものを利用して行えるものである。
Furthermore, coating materials for microcapsules include vinylidene chloride, polyethylene, polypropylene, nylon,
Synthetic resin materials such as silicone and polymeric materials such as gelatin can also be encapsulated in the same manner as above, and known chemical, physical,
This can be done using mechanical equipment.

なお、人工臓器としては、人工心臓装置、人工心肺装置
、人工血管について説明したが、人工腎臓、人工肝臓等
の人工臓器の開発、研究についても同様に利用できるも
のである。
Although the artificial heart device, the heart-lung machine, and the artificial blood vessel have been described as artificial organs, the present invention can also be used for the development and research of artificial organs such as an artificial kidney and an artificial liver.

発明の効果 以上のように本発明にあっては、所要の流体等を簡単に
入手できて容易に生成でき、また低温保存や冷凍保存等
による特別な保存が不要で取扱いが容易であり、しかも
血液と同様の非二ニートン流体の標準となる流体特性が
得られ、人工m器による血球の破壊や血液の流れ分布等
のシミュレーションデータも正確に採取できるもので、
人工臓器の開発、研究のために一段の促進がはかれるも
のである。
Effects of the Invention As described above, the present invention allows the necessary fluids to be easily obtained and produced, does not require special storage such as low-temperature storage or frozen storage, and is easy to handle. It is possible to obtain standard fluid properties for non-Ninton fluids similar to blood, and it is also possible to accurately collect simulation data such as destruction of blood cells by artificial devices and blood flow distribution.
This will further promote the development and research of artificial organs.

Claims (3)

【特許請求の範囲】[Claims] (1)生理食塩水、グリセリン溶液等の安価で取扱い容
易で、入手簡単なニュートン流体に生理食塩水、グリセ
リン溶液等の安価で取扱い容易で、入手簡単な流体を芯
物質とした直径が数ミクロンないし十数ミクロン位のマ
イクロカプセルを混合するとともに、人工臓器の開発や
動作特性、血流等の研究用に血液と同一または類似の流
体特性とするために上記ニュートン流体とマイクロカプ
セルとの体積比率を血液中の血漿水と血球の体積比率と
ほぼ同様に混合形成したことを特徴とする人工臓器研究
用等の血液代替流体。
(1) Cheap, easy-to-handle, easily-obtained Newtonian fluids such as physiological saline and glycerin solutions, and core materials of several microns in diameter using inexpensive, easy-to-handle, and easily obtainable fluids such as physiological saline and glycerin solutions. In addition to mixing microcapsules of about 10-10 microns in size, the volume ratio of the Newtonian fluid and microcapsules is determined in order to obtain fluid characteristics that are the same or similar to blood for research on the development of artificial organs, operating characteristics, blood flow, etc. A blood substitute fluid for artificial organ research, etc., characterized by being formed by mixing plasma water and blood cells in a volume ratio that is almost the same as in blood.
(2)マイクロカプセルを、赤血球の形状のように円盤
状の偏平体に形成したものである特許請求の範囲第1項
記載の人工臓器研究用等の血液代替流体。
(2) A blood substitute fluid for use in artificial organ research, etc., as set forth in claim 1, wherein microcapsules are formed into disk-shaped flat bodies like the shape of red blood cells.
(3)人工臓器の使用によって血球の破壊特性等を測定
するためにマイクロカプセルに内包する流体を、混合す
るニュートン流体と異質なものまたはニュートン流体と
混合しても濃度、色度、重量等の分析によって血球の破
壊度の測定が可能なように糖分、染料、油性分、反応液
等を装填したものである特許請求の範囲第1項または第
2項記載の人工臓器研究用等の血液代替流体。
(3) The fluid encapsulated in microcapsules to measure the destructive characteristics of blood cells through the use of artificial organs may be different from the Newtonian fluid to be mixed, or even if mixed with the Newtonian fluid, the concentration, chromaticity, weight, etc. A blood substitute for artificial organ research, etc., as set forth in claim 1 or 2, which is loaded with sugar, dye, oil, reaction liquid, etc. so that the degree of destruction of blood cells can be measured by analysis. fluid.
JP20364585A 1985-09-15 1985-09-15 Blood-substituting fluid for research of artificial organ or the like Pending JPS6263863A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP20364585A JPS6263863A (en) 1985-09-15 1985-09-15 Blood-substituting fluid for research of artificial organ or the like

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20364585A JPS6263863A (en) 1985-09-15 1985-09-15 Blood-substituting fluid for research of artificial organ or the like

Publications (1)

Publication Number Publication Date
JPS6263863A true JPS6263863A (en) 1987-03-20

Family

ID=16477473

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20364585A Pending JPS6263863A (en) 1985-09-15 1985-09-15 Blood-substituting fluid for research of artificial organ or the like

Country Status (1)

Country Link
JP (1) JPS6263863A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8015677B2 (en) * 2000-12-01 2011-09-13 Aard-Balm Limited Embalming fluid
CN107213929A (en) * 2017-06-06 2017-09-29 国家纳米科学中心 A kind of micro-nano particle piece-rate system based on interfacial effect

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8015677B2 (en) * 2000-12-01 2011-09-13 Aard-Balm Limited Embalming fluid
CN107213929A (en) * 2017-06-06 2017-09-29 国家纳米科学中心 A kind of micro-nano particle piece-rate system based on interfacial effect

Similar Documents

Publication Publication Date Title
CA1305913C (en) Tissue equivalent test systems
JP4177110B2 (en) Patch for screening a subject's sensitization state against allergen and method of use thereof
Jones et al. Free and bound water in elastic and non-elastic gels
US20130143230A1 (en) Microfluidic-based cell-culturing platform and method
JPS603367B2 (en) Leukocyte separation method and leukocyte separation material
US6093551A (en) Process and device for in vitro diagnosis of allergic disorders
AU2023206086A1 (en) Bioreactor and method of use of such bioreactor
US3682172A (en) Parabiotic dialysis apparatus
JPS6263863A (en) Blood-substituting fluid for research of artificial organ or the like
CN112704579B (en) Method for simulating and evaluating platelet adhesion in blood contact medical instrument in vitro
Champion et al. Shear fragility of human erythrocytes
JPH034863B2 (en)
Dintenfass Red cell aggregation in cardiovascular diseases and crucial role of inversion phenomenon
Mason Some methods for in vitro estimation of the blood compatibility of biomaterials.
Grabowski Platelet aggregation in flowing blood in vitro. I. Production by controlled ADP convective diffusion and quantification by videodensitometry
Valvano The use of thermal diffusivity to quantify tissue perfusion
CN210572232U (en) Dynamic simulation device for metal in-vitro degradation research
EP0172822B1 (en) Method for analysis of the activity of receptors of certain cells
Keshaviah Hemolysis in the accelerated flow region of an abrupt contraction.
US20220406222A1 (en) Perfusive tissue phantom
US20110086363A1 (en) Method and apparatus to conduct kinetic analysis of platelet function in whole blood samples
Christodoulides et al. Tracking Fibrinolysis of Chandler Loop-formed Whole Blood Clots Under Shear Flow in An In-vitro Thrombolysis Model
Seifriz The physical properties of protoplasm
RU21741U1 (en) DEVICE FOR MEDICAL AND BIOLOGICAL RESEARCH OF MATERIAL PROPERTIES
Caflisch et al. In situ micropuncture study of pancreatic duct pH